Invest in growth companies making a difference

Sciety makes it possible to become a shareholder in selected companies in the life science sector. Online and free of charge.

Current companies



Normal Pressure Hydrocephalus (NPH) is a significantly underdiagnosed condition with dementia-like symptoms. Even though up to 80% of the NPH population get better after surgery, only about 20% get the correct treatment. Lack of reliable diagnostics is one reason for this undertreatment.

Likvor offers a patented and CE certified system that helps caregivers to diagnose the condition and follow-up treatment results by measuring the dynamics of the spinal fluid in the brain.

The company has clients in six countries in Europe and had a revenue of 3.7 MSEK in 2017. Consumables account for an increasing share of the revenue. The market is growing and ageing populations around the world drives market demand.

Learn more or become a member for complete information and invitations to company presentations. For company information in English please contact us.

Important information: please note that investments in shares carry risk. More information is available here and in our FAQ.

Sciety is a digital investment network

Sciety combines medical and business competence to select promising growth companies in the life science sector. We give you the opportunity to invest in unlisted companies within digital health, medical technology and more.

Qualified companies

Sciety takes care of selection and vetting, and manages the complete investment process. We offer investment opportunities in companies with the potential to give return on investment and make a difference.

Straightforward to invest

As a member, you will find all investment information online and you will also be invited to meet with the companies at our investor lunches.

Selling the share

Invest online and free of charge. You will own your shares directly in the companies and join their expansion. We focus on companies with clear exit plans.


Sciety raises new capital to MedTech company in neurology and cancer


CARTANA raised almost 10 MSEK in a share issue that was fully subscribed at the end of September. The company has developed reagents for analysing tissue samples in drug development…

Läs mer

New venture at Sciety – wants to help researchers in the search for new treatments


Cartana is based at Karolinska Institutet in Stockholm and has developed a new technology for researchers to analyse tissue samples in drug development processes. The company is ready to launch…

Läs mer

Invest with us

Sciety gives members the opportunity to invest in unlisted growth companies with the potential to give return on investment and make a difference. We specialise in the life science sector.